ZC3H15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.869200E-01
Normal-vs-Stage2
4.736000E-01
Normal-vs-Stage3
8.184800E-01
Normal-vs-Stage4
1.260440E-01
Stage1-vs-Stage2
9.802800E-01
Stage1-vs-Stage3
3.592600E-01
Stage1-vs-Stage4
2.388000E-01
Stage2-vs-Stage3
2.987600E-01
Stage2-vs-Stage4
1.016590E-01
Stage3-vs-Stage4
8.144200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.172200E-01
Normal-vs-AfricanAmerican
2.452200E-01
Normal-vs-Asian
7.206200E-01
Caucasian-vs-AfricanAmerican
2.365600E-01
Caucasian-vs-Asian
6.615200E-01
AfricanAmerican-vs-Asian
2.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.792400E-01
Normal-vs-Female
5.417400E-01
Male-vs-Female
5.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.733200E-01
Normal-vs-Age(41-60Yrs)
2.747800E-01
Normal-vs-Age(61-80Yrs)
6.568200E-01
Normal-vs-Age(81-100Yrs)
4.278200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.441380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.825800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.408000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.702300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.892000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.935200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.981400E-01
Normal-vs-Daily Drinker
9.389000E-01
Normal-vs-Weekly Drinker
7.714600E-01
Normal-vs-Occasional Drinker
1.897200E-01
Normal-vs-Social Drinker
6.206400E-01
Non Drinker-vs-Daily Drinker
4.876600E-01
Non Drinker-vs-Weekly Drinker
9.231400E-01
Non Drinker-vs-Occasional Drinker
3.947900E-02
Non Drinker-vs-Social Drinker
6.436600E-01
Daily Drinker-vs-Weekly Drinker
5.131200E-01
Daily Drinker-vs-Occasional Drinker
1.220220E-02
Daily Drinker-vs-Social Drinker
3.090000E-01
Weekly Drinker-vs-Occasional Drinker
1.037610E-01
Weekly Drinker-vs-Social Drinker
7.611000E-01
Occasional Drinker-vs-Social Drinker
1.698040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.951400E-01
Normal-vs-Grade 2
6.998500E-02
Normal-vs-Grade 3
5.039600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.276400E-02
Grade 1-vs-Grade 3
7.843900E-03
Grade 1-vs-Grade 4
2.951400E-01
Grade 2-vs-Grade 3
3.847400E-01
Grade 2-vs-Grade 4
6.998500E-02
Grade 3-vs-Grade 4
5.039600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.308600E-01
Normal-vs-NonDiabetic
5.753200E-01
Diabetic-vs-NonDiabetic
5.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.707000E-01
Normal-vs-NoPancreatitis
5.761200E-01
Pancreatitis-vs-NoPancreatitis
4.770200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.597200E-01
Normal-vs-N1
4.601600E-01
N0-vs-N1
4.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.828210E-01
Normal-vs-TP53-NonMutant
6.131600E-01
TP53-Mutant-vs-TP53-NonMutant
8.080300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
